drugset / Trial / NCT00151840
Efficacy and Safety of IVIG-L in ITP Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The efficacy and safety of a liquid intravenous immunoglobulin product, IVIG-L, in patients with ITP will be assessed and compared with data obtained from literature.
Timeline
- Start
- 2001-10
- Primary completion
- —
- Completion
- 2002-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IVIG-L | Protein / enzyme biologic | — | Intravenous |